News and Info

Welcome to the News and Information section of the ECOG-ACRIN Cancer Research Group website. The materials posted in this section are intended to keep constituents informed of the latest news and activities of the organization. The information below includes press releases, announcements, media advisories, and links to news articles.

We welcome inquiries from members of the press regarding the information posted on this website. To place a media inquiry, contact the Office of Communications.


Latest News

December 15, 2022
December 15, 2022
Categories

Study E1910 consolidates the role of blinatumomab in acute lymphoblastic leukemia (ALL)

Do you like it?
Read more
December 14, 2022
December 14, 2022
Categories

Blinatumomab further improves survival among patients with B-ALL and a good prognosis (study E1910)

Do you like it?
Read more
December 13, 2022
December 13, 2022
Categories

Immunotherapy Plus Consolidation Chemo Improves Survival in B Lineage ALL

Do you like it?
Read more
December 13, 2022
December 13, 2022
Categories

HealthDay News informs the public of the 12-year TAILORx results

Do you like it?
Read more
December 13, 2022
December 13, 2022
Categories

Blinatumomab regimen may lead to ‘diminishing use of transplant’ for B-ALL subgroup (study E1910)

Do you like it?
Read more
December 13, 2022
December 13, 2022
Categories

Press Release: Practice-changing trial results for acute lymphoblastic leukemia (ALL)

Do you like it?
Read more
December 11, 2022
December 11, 2022
Categories

Press Release: A unique clinical trial leads to a dramatic decrease in early deaths from the rare and aggressive—yet highly curable—acute promyelocytic leukemia (APL)

Do you like it?
Read more
December 6, 2022
December 6, 2022
Categories

Press Release: The TAILORx trial in over 10,000 women with early breast cancer reaches 12 years of recurrence and survival outcomes

Do you like it?
Read more
October 28, 2022
October 28, 2022
Categories

Press Release: NCI Director Monica Bertagnolli delivers her first public speech at the ECOG-ACRIN Cancer Research Group meeting

Do you like it?
Read more
October 26, 2022
October 26, 2022
Categories

Press Release: NCI-MATCH cancer trial finds a promising signal for the AKT inhibitor ipatasertib

Do you like it?
Read more
October 21, 2022
October 21, 2022
Categories

Press Release: Head and neck cancer researchers demonstrate the capability of a deep learning algorithm in the post-surgery setting to assess the stage of disease more accurately using standard CT scans

Do you like it?
Read more
October 20, 2022
October 20, 2022
Categories

Press Release: ECOG-ACRIN taps the University of Pennsylvania’s Selina Luger to lead its Leukemia Committee

Do you like it?
Read more
October 13, 2022
October 13, 2022
Categories

The September/October 2022 News from ECOG-ACRIN blog is now available

Do you like it?
Read more
October 4, 2022
October 4, 2022
Categories

DREAMseq trial clarifies immunotherapy, targeted treatment order for patients with BRAF-mutant metastatic melanoma

Do you like it?
Read more
September 30, 2022
September 30, 2022
Categories

Advanced melanoma survival improves significantly when immunotherapy is given before targeted therapy

Do you like it?
Read more
September 28, 2022
September 28, 2022
Categories

Immunotherapy before targeted therapy improves survival in advanced melanoma, according to the DREAMseq trial

Do you like it?
Read more
September 27, 2022
September 27, 2022
Categories

Media Advisory: Journal of Clinical Oncology publishes outcomes from the practice-changing DREAMseq trial in patients with advanced melanoma

Do you like it?
Read more
September 26, 2022
September 26, 2022
Categories

The Fall 2022 advocacy blog Considering Clinical Trials is now available

Do you like it?
Read more
September 8, 2022
September 8, 2022
Categories

Press Release: ECOG-ACRIN completes the first randomized phase 3 clinical trial of neoadjuvant immunotherapy in patients with kidney cancer

Do you like it?
Read more
August 16, 2022
August 16, 2022
Categories

The August 2022 News from ECOG-ACRIN blog is now available

Do you like it?
Read more
Load more
News and Info

About Us Home Page

News and Info
Media Contact:
Diane Dragaud, MA
Director of Communications

Send an email

215-789-3631

Categories


Tags

Acute lymphoblastic leukemia (ALL) Acute myeloid leukemia (AML) Advocacy Bladder cancer Breast cancer Cancer screening Cancer treatment Care delivery Chemotherapy Clinical trial ComboMATCH Disparities Diversity Gastric cancer Gene testing GI cancer Glioblastoma Group meeting Head and neck cancer Health equity Immunotherapy In memory Leadership Leukemia Lung cancer Lymphoma Melanoma Mentorship Multiple myeloma NCI-MATCH Pancreatic cancer Personalized screening Personalized treatment Precision medicine Precision oncology Prostate cancer Radiology Real world data Research results Sarcoma Skin cancer Social determinants of health (SDoH) Survivorship TMIST Treatment trial

 
ECOG-ACRIN Cancer Research Group